Table 2.
Mycotoxins risk assessment based on the mycotoxin biomarker urinary levels among the participants.
| Mean Positive Samples | Lower Bound Scenario | Upper Bound Scenario | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mycotoxin | Tolerable Daily Intake (µg/ kg bw/day) | Mean PDI (µg/kg bw/day |
%TDI | Mean PDI (µg/kg bw/day |
%TDI | Mean PDI (µg/kg bw/day |
%TDI | ||||||
| Males | Females | Males | Females | Males | Females | Males | Females | Males | Females | Males | Females | ||
| DON | 1 | 0.25 | 0.30 | 25% | 30% | 0.052 | 0.063 | 5.2% | 6.3% | 0.055 | 0.067 | 5.5% | 6.7% |
| Total DON: (DON+DOM-1) | 1 | 0.76 | 0.92 | 76% | 92% | 0.322 | 0.393 | 32.2% | 39.3% | 0.329 | 0.402 | 32.9% | 40.2% |
| ZEA | 0.25 | 1.23 | 1.50 | 492% | 600% | 0.49 | 0.6 | 196% | 240% | 0.53 | 0.64 | 212% | 256% |
| Total ZEA: (ZEA, ZEA-14 -Glc, αZOL, αZOL-14 -Glc) | 0.25 | 10.87 | 13.27 | 4348% | 5308% | 3.49 | 4.25 | 1396% | 1700% | 3.66 | 4.46 | 1464% | 1784% |
| OTA | 0.12 | 0.42 | 0.52 | 350% | 433% | 0.01 | 0.01 | 8.3% | 10.8% | 0.06 | 0.08 | 50% | 66.7% |